Menu Search
Equities

Intuitive Surgical Inc

ISRG:NSQ

Intuitive Surgical Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)538.51
  • Today's Change-9.37 / -1.71%
  • Shares traded237.05k
  • 1 Year change+69.34%
  • Beta1.3902
Data delayed at least 15 minutes, as of Nov 25 2024 15:44 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Intuitive Surgical Inc grew revenues 14.49% from 6.22bn to 7.12bn while net income improved 35.98% from 1.32bn to 1.80bn.
Gross margin66.98%
Net profit margin28.73%
Operating margin26.24%
Return on assets13.93%
Return on equity15.95%
Return on investment15.63%
More ▼

Cash flow in USDView more

In 2023, Intuitive Surgical Inc increased its cash reserves by 73.06%, or 1.17bn. The company earned 1.81bn from its operations for a Cash Flow Margin of 25.46%. In addition the company used 360.10m on investing activities and also paid 287.60m in financing cash flows.
Cash flow per share7.65
Price/Cash flow per share70.75
Book value per share43.75
Tangible book value per share42.70
More ▼

Balance sheet in USDView more

Intuitive Surgical Inc has a strong Balance Sheet and has consistently grown its cash reserves over the last Four years to total 2.75bn.
Current ratio4.30
Quick ratio3.42
Total debt/total equity0.00
Total debt/total capital0.00
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 37.73%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
EPS growth(5 years)9.70
EPS (TTM) vs
TTM 1 year ago		46.49
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.